Pfizer
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Pfizer's balance sheet done over the years? Its assets were worth $226,501,000,000 last year, which is more than in the previous period. 61% of Pfizer’s total assets is currently financed by debt. Its liabilities reached the amount of $137,213,000,000, which means an increase by 35% compared compared to last year.
Debt to Assets
| 2014 | 169274000000 | 97.65B | 57.69% |
|---|---|---|---|
| 2015 | 167460000000 | 102.46B | 61.19% |
| 2016 | 171615000000 | 111.77B | 65.13% |
| 2017 | 171797000000 | 100.14B | 58.29% |
| 2018 | 159422000000 | 95.66B | 60.01% |
| 2019 | 167488000000 | 104.04B | 62.12% |
| 2020 | 154229000000 | 90.75B | 58.84% |
| 2021 | 181477000000 | 104.01B | 57.32% |
| 2022 | 197206000000 | 101.28B | 51.36% |
| 2023 | 226501000000 | 137.21B | 60.58% |
PFE Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 2.85B | 416M | 1.94B | 1.78B | 1.30B | 1.13B | 1.34B | 2.59B | 3.64B | 3.34B |
Short term investments | 9.83B | 22.31B | 29.12B | 10.43B | 8.52B | 17.69B | 18.65B | 15.25B | 19.64B | 32.77B |
Net receivables | 11.17B | 14.52B | 15.74B | 11.19B | 12.06B | 11.39B | 8.22B | 11.26B | 8.17B | 8.40B |
Inventory | 10.18B | 8.98B | 9.05B | 8.04B | 8.28B | 7.50B | 7.57B | 6.78B | 7.51B | 5.66B |
Other current assets | 9.27B | 5.01B | 3.82B | 3.43B | 2.60B | 2.46B | 5.33B | 2.24B | 4.82B | 7.51B |
Total current assets | 43.33B | 51.25B | 59.69B | 35.06B | 32.80B | 49.92B | 41.14B | 38.94B | 43.80B | 57.70B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 21.86B | 16.27B | 14.88B | 13.9B | 13.96B | 13.38B | 13.86B | 13.31B | 13.76B | 11.76B |
Goodwill | 67.78B | 51.37B | 49.20B | 49.57B | 58.65B | 53.41B | 55.95B | 54.44B | 48.24B | 42.06B |
Intangible assets | 64.9B | 43.37B | 25.14B | 28.47B | 35.36B | 35.21B | 48.74B | 52.64B | 40.35B | 35.16B |
Long term investments | 15.77B | 15.06B | 21.52B | 20.26B | 20.14B | 2.76B | 7.01B | 7.11B | 15.99B | 17.51B |
Other non-current assets | 9.14B | 13.16B | 7.67B | 4.56B | 4.45B | 2.79B | 3.22B | 3.32B | 3.49B | 3.51B |
Total non-current assets | 183.16B | 145.94B | 121.78B | 119.16B | 134.68B | 109.49B | 130.65B | 132.66B | 123.65B | 111.57B |
Total assets | 226.50B | 197.20B | 181.47B | 154.22B | 167.48B | 159.42B | 171.79B | 171.61B | 167.46B | 169.27B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 2.7B | 2.52B | 3.06B | 6.26B | 5.80B | 5.70B | 4.70B | 4.86B | 4.62B | 4.02B |
Short term debt | 10.34B | 2.94B | 2.24B | 2.70B | 16.19B | 8.83B | 9.95B | 10.68B | 10.16B | 5.14B |
Total current liabilities | 47.79B | 42.13B | 42.67B | 25.92B | 37.30B | 31.85B | 30.42B | 31.11B | 29.39B | 21.63B |
| Non-current liabilities: | ||||||||||
Long term debt | 61.53B | 31.92B | 34.75B | 35.57B | 35.95B | 32.42B | 6.53B | 31.39B | 16.70B | 18.58B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 27.24B | 26.20B | 9.74B | 6.66B | 6.31B | 5.85B | 5.27B | 6.33B | 5.25B | 6.54B |
Total non-current liabilities | 89.41B | 59.15B | 61.34B | 64.83B | 66.73B | 63.80B | 69.71B | 80.66B | 73.06B | 76.02B |
Total liabilities | 137.21B | 101.28B | 104.01B | 90.75B | 104.04B | 95.66B | 100.14B | 111.77B | 102.46B | 97.65B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |